logo

CAMP

CAMP4 Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.75 / 10
Netural

Analyst coverage shows 2 buys and 1 neutral, with mixed historical performance. Fund‑flow score is 7.81/10, indicating strong inflows across most investor sizes except small traders. Sentiment is neutral (5.75). Overall, liquidity is healthy but analyst confidence is modest.

FundamentalSentiment(5.75)Technical
Fund Flow Rating
Analyst RatingBuy

Wall Street Opinions

Buy

Strong Buy

0%

Buy

67%

Hold

0%

Sell

0%

Strong Sell

0%

Date2025-09-16
InstitutionJP Morgan
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for CAMP?
  • CAMP holds a Bearish analyst rating, with 67% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.75/10 (Netural).